1. At a Glance – Blink and You’ll Miss the Irony
Excel Industries is that quiet kid in the specialty chemicals class who once topped the exams, then decided to meditate for a decade while others built unicorns. With a market cap of ₹1,161 Cr, a current price of ₹924, and a price-to-book of just 0.64, this stock is officially cheaper than its own balance sheet furniture.
Latest Q3 FY26 numbers show ₹233.5 Cr revenue and ₹8.44 Cr PAT, translating into a 36% QoQ profit jump. Sounds sexy? Wait. ROCE is still stuck at 7.11%, ROE at 5.21%, and 5-year sales growth is a sleepy 6.8%.
The stock is down 27% in 6 months and 29% in 1 year, while still paying a 1.49% dividend yield—basically saying: “I won’t grow fast, but I’ll at least buy you samosas.”
Is this a turnaround brewing or just another false chemical reaction? Let’s open the lab notebook.
2. Introduction – A Legacy Chemical Player Having a Mid-Life Crisis
Excel Industries Ltd has been around long enough to see chlorpyrifos go from hero to villain. Once a cash-printing machine during the agrochemical boom, Excel today finds itself balancing between legacy phosphorus chemistry, pharma APIs, and a tiny environmental solutions hobby.
Historically, this company knew how to make money when organophosphorus chemistry ruled farms. But regulation tightened, exports slowed, and suddenly Excel’s once-mighty DETC began behaving like that overqualified employee stuck in a boring role.
The last few years have been about capex, diversification, automation, and waiting. And waiting. And waiting some more.
So when Q3 FY26 shows a sharp QoQ recovery, investors naturally ask:
Is Excel finally waking up—or just stretching before another nap?
3. Business Model – WTF Do They Even Do?
Excel Industries is basically a phosphorus chemistry specialist pretending to be diversified.
Chemicals Segment (98% of FY24 revenue)
This is where the real action is:
- Agrochemical intermediates:
P2S5, PCl3, PCl5, PSCl3, and the star of the show—DETC, which alone contributes ~40% of
